Literature DB >> 8481038

The natural history of congenital myotonic dystrophy: mortality and long term clinical aspects.

W Reardon1, R Newcombe, I Fenton, J Sibert, P S Harper.   

Abstract

Although the genetic basis of the congenital form of myotonic dystrophy has recently been clarified, data as to outcome in terms of life expectancy and morbidity are scanty. Life table data based on a cohort of 115 patients with a confirmed diagnosis of congenital myotonic dystrophy are presented. The data suggest a 25% chance of death before 18 months of age and a 50% chance of survival into the mid-30s. The profile of disease and complications among survivors is also charted.

Entities:  

Mesh:

Year:  1993        PMID: 8481038      PMCID: PMC1029229          DOI: 10.1136/adc.68.2.177

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  17 in total

1.  Unstable DNA sequence in myotonic dystrophy.

Authors:  H G Harley; S A Rundle; W Reardon; J Myring; S Crow; J D Brook; P S Harper; D J Shaw
Journal:  Lancet       Date:  1992-05-09       Impact factor: 79.321

2.  MYOTONIC DYSTROPHY IN INFANCY AND CHILDHOOD.

Authors:  P R DODGE; I GAMSTORP; R K BYERS; P RUSSELL
Journal:  Pediatrics       Date:  1965-01       Impact factor: 7.124

3.  Dystrophia myotonica in childhood.

Authors:  T M VANIER
Journal:  Br Med J       Date:  1960-10-29

Review 4.  Genomic imprinting: review and relevance to human diseases.

Authors:  J G Hall
Journal:  Am J Hum Genet       Date:  1990-05       Impact factor: 11.025

5.  Anal abnormalities in childhood myotonic dystrophy--a possible source of confusion in child sexual abuse.

Authors:  W Reardon; H E Hughes; S H Green; V Lloyd Woolley; P S Harper
Journal:  Arch Dis Child       Date:  1992-04       Impact factor: 3.791

6.  Congenital myotonic dystrophy in Britain. I. Clinical aspects.

Authors:  P S Harper
Journal:  Arch Dis Child       Date:  1975-07       Impact factor: 3.791

Review 7.  Genetic imprinting in clinical genetics.

Authors:  A Clarke
Journal:  Dev Suppl       Date:  1990

8.  Expansion of an unstable DNA region and phenotypic variation in myotonic dystrophy.

Authors:  H G Harley; J D Brook; S A Rundle; S Crow; W Reardon; A J Buckler; P S Harper; D E Housman; D J Shaw
Journal:  Nature       Date:  1992-02-06       Impact factor: 49.962

9.  Detection of an unstable fragment of DNA specific to individuals with myotonic dystrophy.

Authors:  J Buxton; P Shelbourne; J Davies; C Jones; T Van Tongeren; C Aslanidis; P de Jong; G Jansen; M Anvret; B Riley
Journal:  Nature       Date:  1992-02-06       Impact factor: 49.962

10.  Cloning of the essential myotonic dystrophy region and mapping of the putative defect.

Authors:  C Aslanidis; G Jansen; C Amemiya; G Shutler; M Mahadevan; C Tsilfidis; C Chen; J Alleman; N G Wormskamp; M Vooijs
Journal:  Nature       Date:  1992-02-06       Impact factor: 49.962

View more
  27 in total

1.  Two children with muscular dystrophies ascertained due to referral for diagnosis of autism.

Authors:  Lonnie Zwaigenbaum; Mark Tarnopolsky
Journal:  J Autism Dev Disord       Date:  2003-04

2.  Knowledge, views, and experience of 25 women with myotonic dystrophy.

Authors:  C L Faulkner; H M Kingston
Journal:  J Med Genet       Date:  1998-12       Impact factor: 6.318

3.  Physical function and mobility in children with congenital myotonic dystrophy.

Authors:  Evan M Pucillo; Deanna L Dibella; Man Hung; Jerry Bounsanga; Becky Crockett; Melissa Dixon; Russell J Butterfield; Craig Campbell; Nicholas E Johnson
Journal:  Muscle Nerve       Date:  2017-02-13       Impact factor: 3.217

4.  12-Month progression of motor and functional outcomes in congenital myotonic dystrophy.

Authors:  Kellen H Quigg; Kiera N Berggren; Melissa McIntyre; Kameron Bates; Francesca Salmin; Jacopo L Casiraghi; Adele DʼAmico; Guja Astrea; Federica Ricci; Marnee J McKay; Jennifer N Baldwin; Joshua Burns; Craig Campbell; Valeria A Sansone; Nicholas E Johnson
Journal:  Muscle Nerve       Date:  2021-01-10       Impact factor: 3.217

5.  GSK3β mediates muscle pathology in myotonic dystrophy.

Authors:  Karlie Jones; Christina Wei; Polina Iakova; Enrico Bugiardini; Christiane Schneider-Gold; Giovanni Meola; James Woodgett; James Killian; Nikolai A Timchenko; Lubov T Timchenko
Journal:  J Clin Invest       Date:  2012-11-19       Impact factor: 14.808

Review 6.  Molecular mechanisms of muscle atrophy in myotonic dystrophies.

Authors:  Lubov Timchenko
Journal:  Int J Biochem Cell Biol       Date:  2013-06-21       Impact factor: 5.085

Review 7.  Congenital myotonic dystrophy: ventriculomegaly and shunt considerations for the pediatric neurosurgeon.

Authors:  Ian S Mutchnick; Meena A Thatikunta; William C Gump; Dan L Stewart; Thomas M Moriarty
Journal:  Childs Nerv Syst       Date:  2016-01-08       Impact factor: 1.475

8.  Outcome of non-invasive positive pressure ventilation in paediatric neuromuscular disease.

Authors:  S Katz; H Selvadurai; K Keilty; M Mitchell; I MacLusky
Journal:  Arch Dis Child       Date:  2004-02       Impact factor: 3.791

9.  Lower gastrointestinal tract disturbance in congenital myotonic dystrophy.

Authors:  Tim P Kerr; Stephanie A Robb; Graham S Clayden
Journal:  Eur J Pediatr       Date:  2002-08       Impact factor: 3.183

10.  Genome Therapy of Myotonic Dystrophy Type 1 iPS Cells for Development of Autologous Stem Cell Therapy.

Authors:  Yuanzheng Gao; Xiuming Guo; Katherine Santostefano; Yanlin Wang; Tammy Reid; Desmond Zeng; Naohiro Terada; Tetsuo Ashizawa; Guangbin Xia
Journal:  Mol Ther       Date:  2016-05-12       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.